- Anaphylaxis to Polyethylene Glycol (Colyte®) in a Patient with Diverticulitis
-
Lee SH, Hwang SH, Park JS, Park HS, Shin YS
- KMID: 2468260
- J Korean Med Sci.
- 2016 Oct;31(10):1662-1663.
- doi: 10.3346/jkms.2016.31.10.1662
Polyethylene glycols (PEGs) are believed to be chemically inert agents, but larger PEG polymers could have immunogenicity. A 39-year-old man was referred to emergency room for loss of consciousness and... -
- CITED
-
- Close
- SHARE
-
- Close
- Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin
-
Lee TH, Lee KO, Kim YS, Kim SM, Huh KC, Choi YW, Kang YW
- KMID: 1792063
- Korean J Intern Med.
- 2014 May;29(3):370-374.
- doi: 10.3904/kjim.2014.29.3.370
Various adverse events have been reported during combination therapy with pegylated (PEG)-interferon-alpha and ribavirin, although opportunistic infections, especially cryptococcal meningitis, are very rare. A 61-year-old woman complained of headaches and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin
-
Kim YH, Han WS, Lee SJ, Oh SN, Choi DW, Byun KS, Yeon JE
- KMID: 760744
- Korean J Hepatol.
- 2007 Sep;13(3):419-422.
- doi: 10.3350/kjhep.2007.13.3.419
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN... -
- CITED
-
- Close
- SHARE
-
- Close
- Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis
-
Kang HY, Shin MC
- KMID: 1364871
- Korean J Ophthalmol.
- 2012 Apr;26(2):147-150.
- doi: 10.3341/kjo.2012.26.2.147
This paper reports a case of pegylated interferon-associated retinopathy in a patient with chronic hepatitis C. A 32-year-old female with chronic hepatitis C undergoing pegylated interferon and ribavirin combination therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C
-
Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH
- KMID: 1381442
- Korean J Hepatol.
- 2009 Jun;15(2):209-215.
- doi: 10.3350/kjhep.2009.15.2.209
A 63-year-old male experienced sudden diplopia after 9 weeks of administration of pegylated interferon (IFN) alpha-2b and ribavirin for chronic hepatitis C (CHC). Ophthalmologic examinations showed ptosis on the right... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Bell's Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
-
Lee MY, Cho H, Kim YM, Lee JS
- KMID: 760677
- Korean J Hepatol.
- 2006 Sep;12(3):444-448.
Pegylated interferon alfa-2a (PEG-IFN) and ribavirin combination therapy is the first line treatment for chronic HCV infection. There are four reports of Bell's palsy associated with interferon-alpha (IFN-alpha) and ribavirin... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C
-
Shin MK, Kim TH, Ju K, Ha CY, Min HJ, Jung WT, Lee OJ
- KMID: 1374966
- Korean J Hepatol.
- 2009 Sep;15(3):370-374.
- doi: 10.3350/kjhep.2009.15.3.370
Combination therapy of pegylated interferon alpha and ribavirin has been associated with various adverse effects, but sudden-onset hearing loss is uncommon. We report a 60-year-old male patient who developed sudden-onset... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of and risk factors for thyroid dysfunction during peginterferon alpha and ribavirin treatment in patients with chronic hepatitis C
-
Hwang Y, Kim W, Kwon SY, Yu HM, Kim JH, Choe WH
- KMID: 2381583
- Korean J Intern Med.
- 2015 Nov;30(6):792-800.
- doi: 10.3904/kjim.2015.30.6.792
BACKGROUND/AIMS: Thyroid dysfunction (TD) is more likely to occur in patients with chronic hepatitis C (CHC) and is particularly associated with interferon (IFN) treatment. The purpose of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C
-
Lim JH, Lee YN, Kim YS, Kim SG, Jeong SW, Jang JY, Kim HS, Lee SH, Park TK
- KMID: 1105515
- Korean J Hepatol.
- 2011 Mar;17(1):61-65.
- doi: 10.3350/kjhep.2011.17.1.61
Vogt-Koyanagi-Harada (VKH) disease is a multisystem syndrome characterized by ocular (uveitis and retinal detachment), neurological (headache, tinnitus, and meningitis), and integumentary (vitiligo, alopecia, and poliosis) involvement. Although the pathogenesis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C
-
Lee YN, Jeong SW, Lim JH, Ryu YS, Jeon SR, Kim SK, Jang JY, Kim YS, Kim BS, Roh MO
- KMID: 1792598
- Korean J Hepatol.
- 2010 Jun;16(2):187-191.
- doi: 10.3350/kjhep.2010.16.2.187
Combined pegylated interferon and ribavirin therapy for chronic hepatitis C infection cause a wide range of side effects, including flu-like syndrome, hematological abnormalities, cardiovascular symptoms, gastrointestinal symptoms, pulmonary dysfunction, depression,... -
- CITED
-
- Close
- SHARE
-
- Close
